Screener
Globus Medical GMED Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Sales and maturities of marketable securities | 21,483 | 174,238 |
| Purchases of property and equipment | (72,783) | (82,665) |
| Acquisition of businesses, net of cash acquired and purchases of intangible and other assets | (6,409) | (257,546) |
| Net cash provided by/(used in) investing activities | (311,722) | (167,723) |
| Cash flows from financing activities: | ||
| Payment of business acquisition-related liabilities | (13,720) | (7,864) |
| Net proceeds from exercise of stock options | 36,932 | 15,920 |
| Payments related to tax withholdings for share-based compensation | (3,453) | (2,953) |
Item 1. Financial Statements
FAQ
- What is Globus Medical's investing cash flow?
- Globus Medical (GMED) reported investing cash flow of -$129.05M in Q2 2026.
- How has Globus Medical's investing cash flow changed year-over-year?
- Globus Medical's investing cash flow increased by 56.9% year-over-year, from -$299.11M to -$129.05M.
- What is the long-term trend for Globus Medical's investing cash flow?
- Over 4 years (2021 to 2025), Globus Medical's investing cash flow has grown at a -1.4% compound annual growth rate (CAGR), from -$375.94M to -$355.01M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Globus Medical's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude